Brief report
Effectiveness and safety of 5-azacitidine in three patients with myelodysplastic syndromes
Efectividad y seguridad de 5-azacitidina en tres pacientes con síndrome mielodisplásico
M.C. Garzás-Martín de Almagro
, A.I. Gago Sánchez, I. Cuevas Asencio, M. Reyes Malia
Unidad de Gestión Clínica de Farmacia, Hospital Universitario Reina Sofía, Córdoba, Spain
Leído
2447
Vecesse ha leído el artículo
1082
Total PDF
1365
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 69 | 29 | 98 |
| 2025 9 | 43 | 18 | 61 |
| 2025 8 | 47 | 37 | 84 |
| 2025 7 | 43 | 40 | 83 |
| 2025 6 | 27 | 29 | 56 |
| 2025 5 | 44 | 24 | 68 |
| 2025 4 | 44 | 26 | 70 |
| 2025 3 | 49 | 28 | 77 |
| 2025 2 | 51 | 23 | 74 |
| 2025 1 | 43 | 37 | 80 |
| 2024 12 | 39 | 25 | 64 |
| 2024 11 | 30 | 19 | 49 |
| 2024 10 | 29 | 15 | 44 |
| 2024 9 | 38 | 18 | 56 |
| 2024 8 | 38 | 24 | 62 |
| 2024 7 | 28 | 19 | 47 |
| 2024 6 | 23 | 9 | 32 |
| 2024 5 | 27 | 14 | 41 |
| 2024 4 | 31 | 15 | 46 |
| 2024 3 | 29 | 14 | 43 |
| 2024 2 | 33 | 14 | 47 |
| 2024 1 | 31 | 15 | 46 |
| 2023 12 | 28 | 18 | 46 |
| 2023 11 | 25 | 27 | 52 |
| 2023 10 | 23 | 8 | 31 |
| 2023 9 | 24 | 28 | 52 |
| 2023 8 | 11 | 15 | 26 |
| 2023 7 | 18 | 16 | 34 |
| 2023 6 | 11 | 21 | 32 |
| 2023 5 | 18 | 24 | 42 |
| 2023 4 | 12 | 6 | 18 |
| 2023 3 | 16 | 13 | 29 |
| 2023 2 | 15 | 21 | 36 |
| 2022 1 | 4 | 6 | 10 |
| 2022 12 | 8 | 3 | 11 |
| 2022 11 | 7 | 6 | 13 |
| 2022 10 | 12 | 7 | 19 |
| 2022 9 | 5 | 8 | 13 |
| 2022 8 | 7 | 7 | 14 |
| 2022 7 | 10 | 8 | 18 |
| 2022 6 | 14 | 8 | 22 |
| 2022 5 | 8 | 5 | 13 |
| 2022 4 | 7 | 9 | 16 |
| 2022 3 | 9 | 8 | 17 |
| 2022 2 | 4 | 2 | 6 |
| 2021 1 | 6 | 5 | 11 |
| 2021 12 | 6 | 9 | 15 |
| 2021 11 | 3 | 8 | 11 |
| 2021 10 | 5 | 9 | 14 |
| 2021 9 | 2 | 7 | 9 |
| 2021 8 | 4 | 8 | 12 |
| 2021 7 | 4 | 10 | 14 |
| 2021 6 | 6 | 4 | 10 |
| 2021 5 | 4 | 7 | 11 |
| 2021 4 | 8 | 8 | 16 |
| 2021 3 | 3 | 8 | 11 |
| 2021 2 | 7 | 5 | 12 |
| 2020 1 | 2 | 7 | 9 |
| 2020 12 | 1 | 6 | 7 |
| 2020 11 | 2 | 4 | 6 |
| 2020 10 | 1 | 4 | 5 |
| 2020 9 | 7 | 10 | 17 |
| 2020 8 | 6 | 6 | 12 |
| 2020 7 | 6 | 11 | 17 |
| 2020 6 | 3 | 5 | 8 |
| 2020 5 | 2 | 7 | 9 |
| 2020 4 | 2 | 4 | 6 |
| 2020 3 | 2 | 3 | 5 |
| 2020 2 | 1 | 3 | 4 |
| 2020 1 | 1 | 1 | 2 |
| 2019 12 | 5 | 10 | 15 |
| 2019 11 | 0 | 2 | 2 |
| 2019 10 | 1 | 4 | 5 |
| 2019 9 | 1 | 2 | 3 |
| 2019 8 | 0 | 3 | 3 |
| 2019 7 | 4 | 4 | 8 |
| 2019 6 | 2 | 15 | 17 |
| 2019 5 | 20 | 14 | 34 |
| 2019 4 | 5 | 14 | 19 |
| 2019 2 | 0 | 4 | 4 |
| 2019 1 | 2 | 1 | 3 |
| 2018 12 | 1 | 2 | 3 |
| 2018 11 | 3 | 0 | 3 |
| 2018 10 | 2 | 13 | 15 |
| 2018 9 | 1 | 2 | 3 |
| 2018 8 | 1 | 0 | 1 |
| 2018 7 | 2 | 6 | 8 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 0 | 2 | 2 |
| 2018 4 | 0 | 3 | 3 |
| 2018 3 | 1 | 1 | 2 |
| 2018 1 | 0 | 3 | 3 |
| 2017 12 | 0 | 1 | 1 |
| 2017 11 | 4 | 0 | 4 |
| 2017 10 | 3 | 3 | 6 |
| 2017 9 | 0 | 2 | 2 |
| 2017 8 | 1 | 0 | 1 |
| 2017 7 | 2 | 1 | 3 |
| 2017 6 | 6 | 5 | 11 |
| 2017 5 | 3 | 3 | 6 |
| 2017 4 | 3 | 3 | 6 |
| 2017 3 | 6 | 26 | 32 |
| 2017 2 | 3 | 4 | 7 |
| 2016 1 | 7 | 1 | 8 |
| 2016 12 | 7 | 0 | 7 |
| 2016 11 | 10 | 0 | 10 |
| 2016 10 | 12 | 2 | 14 |
| 2016 9 | 6 | 0 | 6 |
| 2016 8 | 11 | 0 | 11 |
| 2016 7 | 4 | 0 | 4 |
Mostrar todo
